4Okabe H. Study on the Constituents of Momordica charantia L I Isolation and Characterization of Momordicosides A and B, Glycosides of Pentahydroxy-cucurbitane Triterpenel[J]. Chem Pharm Bu11,1980,28(9):2753-2762.
5Scrow W. Inhahsstoffe vo Momordiea charantia L Ⅰ1)△^5-25-Sigmastadie enol--(3β)und sein β-D-Glucosid[J]. Chem Ber,1966,99(9):2765-2777.
6Sucrow W. Inhahsstoffe vo Momordiea charantia L.,Ⅱ1)Zwei neue △7-Sterine aus Momordica charantia[J]. Chem Ber, 1966,99(11):3559-3567.
7Leung So. The immuno suppressive activities of two abortifaccient proteins isolated from the seeds of bitter melon.Immunopharmacology, 1987,13(3): 159.
8Niwa Y. Pole of cytokines, tyrosine kinase, and protein kinase Con production of super oxide and induction of sca venenging enzymes. In human Leukocytes[J]. Clin Im munol In munopathol,1996,79(3):303.
9Shibib B A, Khan La, Rahan R. Hypoglycaemic activity of Coccinia indica and Momodica aharantia on diabetic rats. Depression of the hepatic gluconeogetic enzymes glucose-6-phosphatase and fructose-1,6-biphosphatase and elevation of dehydrogenase [J]. Biochem J, 1993,292 (1):267-270.
10Lee Huang S.Map30:a new inhibitor of HIV-1 infection and replication. FEBS lett,1990,272(1-2):12-18.
8Virdi J, Sivakami S, Shahani S, et al. Antihyperglycemic effects of three extracts from Momordica charantia [J]. J Ethnopharmacol, 2003, 88 (1): 107-111.
9Sarkar S, Pranava M, Marita A R. Demonstration of the hypoglycemic action of Momordica charantiain a validated animal model of diabetes [J]. Pharmacological Research, 1996, 33(1): 14.
